Risk for Venous Thromboembolism in Patients With Superficial Venous Thrombosis
Authors: Matias E. Valsecchi
Journal: Annals of Internal Medicine (2010)

Letters6 July 2010Risk for Venous Thromboembolism in Patients With Superficial Venous ThrombosisMatias E. Valsecchi, MDMatias E. Valsecchi, MDFrom Albert Einstein Medical Center, Philadelphia, PA 19141.Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-153-1-201007060-00025 SectionsAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail TO THE EDITOR:I found the article by Decousus and colleagues (1) very interesting in relation to the apparently not-so-benign course of symptomatic SVT. This study adds more evidence for the need to screen for DVT in patients with SVT and raises valid questions about the potential benefit of systemic anticoagulation. However, this is known to be a heterogenic population, and patients who will definitely benefit from full anticoagulation are those with thrombophilic disorders. It is striking that even though Decousus and colleagues describe only 5% of known biological thrombophilia, in patients who had only isolated SVT at diagnosis, more ...References1. Decousus H, Quéré I, Presles E, Becker F, Barrellier MT, Chanut M, et al; POST (Prospective Observational Superficial Thrombophlebitis) Study Group. Superficial venous thrombosis and venous thromboembolism: a large, prospective epidemiologic study. Ann Intern Med. 2010;152:218-24. [PMID: 20157136] LinkGoogle Scholar2. Martinelli I, Cattaneo M, Taioli E, De Stefano V, Chiusolo P, Mannucci PM. Genetic risk factors for superficial vein thrombosis. Thromb Haemost. 1999;82:1215-7. [PMID: 10544900] CrossrefMedlineGoogle Scholar3. de Godoy JM, Batigália F, Braile DM. Superficial thrombophlebitis and anticardiolipin antibodies—report of association. Angiology. 2001;52:127-9. [PMID: 11228085] CrossrefMedlineGoogle Scholar Author, Article, and Disclosure InformationAuthors: Matias E. Valsecchi, MDAffiliations: From Albert Einstein Medical Center, Philadelphia, PA 19141.Disclosures: None disclosed. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetailsSee AlsoSuperficial Venous Thrombosis and Venous Thromboembolism Hervé Decousus , Isabelle Quéré , Emilie Presles , François Becker , Marie-Thérèse Barrellier , Myriam Chanut , Jean-Luc Gillet , Hervé Guenneguez , Christine Leandri , Patrick Mismetti , Olivier Pichot , and Alain Leizorovicz , for the POST (Prospective Observational Superficial Thrombophlebitis) Study Group* Risk for Venous Thromboembolism in Patients With Superficial Venous Thrombosis Hervé Decousus , Isabelle Quéré , and Alain Leizorovicz Risk for Venous Thromboembolism in Patients With Superficial Venous Thrombosis Michael S. Lauer Risk for Venous Thromboembolism in Patients With Superficial Venous Thrombosis Claude Bachmeyer Metrics 6 July 2010Volume 153, Issue 1Page: 63KeywordsClinical trialsConflicts of interestInformation retrievalPulmonary embolismThrombosisVenous thromboembolism ePublished: 6 July 2010 Issue Published: 6 July 2010 Copyright & PermissionsCopyright © 2010 by American College of Physicians. All Rights Reserved.PDF downloadLoading ...